Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EX
- Chemical substanceL01EX17Capmatinib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Netherlands
CBG-MEB · 2 registrations
Singapore
HSA · 2 registrations
At a glance
- ATC code
- L01EX17
- Registers
- 6
- Registrations
- 9
- With their own page
- 9
- Companies
- 4
All medicines with Capmatinib
Human medicines from every register that match Capmatinib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
12 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tabrecta | United States | 150MG BASE, 200MG BASE | tablet | Marketed | Novartis Pharm |
| Tabrecta | European Union | Authorised | Novartis Europharm Limited | ||
| Tabrecta 150mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Novartis Europharm Limited | |
| Tabrecta 200mg, filmomhulde tabletten | Netherlands | Filmomhulde tablet | Authorised | Novartis Europharm Limited | |
| Tabrecta | Canada | 150 MG | Tablet | Marketed | Novartis Pharmaceuticals Canada INC |
| Tabrecta | Canada | 200 MG | Tablet | Marketed | Novartis Pharmaceuticals Canada INC |
| TABRECTA FILM-COATED TABLET 150mg | Singapore | 150mg | tablet, film coated | Authorised | Novartis (Singapore) Pte LTD |
| TABRECTA FILM-COATED TABLET 200mg | Singapore | 200mg | tablet, film coated | Authorised | Novartis (Singapore) Pte LTD |
| Tabrecta | Croatia | Marketed | |||
| Tabrecta 150 MG Comprimidos Recubiertos con Pelicula | Spain | 183 mg | comprimido recubierto con película | Marketed | Novartis Europharm Limited |
| Tabrecta 200 MG Comprimidos Recubiertos con Pelicula | Spain | 244 mg | comprimido recubierto con película | Marketed | Novartis Europharm Limited |
| Tabrecta | Brazil | Cancelled | Novartis Biociencias S.A |